×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The Who, What, How, When, and Why of Using Mobile Technology in Clinical Trials
Session Chair(s)
Robert DiCicco, PharmD
Vice President, Portfolio Management
TransCelerate Biopharma Inc., United States
Panelists will discuss how they have implemented recommendations from CTTI’s Mobile Clinical Trials projects to advance the use of mobile technology in clinical trials, as well as how others can adopt these strategies.
Learning Objective : Describe recommendations for successfully incorporating mobile technology in regulatory submission trials; Identify approaches for developing novel endpoints, overcoming legal and regulatory barriers, and incorporating mobile devices in clinical trials while accounting for site and patient perspectives; Discuss opportunities to implement recommendations in attendee organizations.
Speaker(s)
Panelist
Cynthia Geoghegan
Patients and Partners LLC, United States
Patient Representative
Panelist
Philip Coran
Medidata Solutions, United States
Principal, Global Compliance and Strategy
Panelist
Jan Hewett, BSN, JD
FDA, United States
Regulatory Counsel for Policy, OSI, CDER
Have an account?